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ABSTRACT
Introduction There is an increased healthcare need to 
manage institutionalised older patients owing to the ageing 
population. To overcome substantial future challenges, 
the Health- RESPECT (caRE Systems for Patients/Elderly 
with Coordinated care using icT), a new information 
and communication technologies based integrated 
management service model, was developed to provide 
effective management, enable consultation with distant 
professionals and share medical information between 
acute care hospitals and long- term care institutions.
Methods and analysis A cluster randomised controlled 
trial will be conducted to examine the effectiveness 
of the Health- RESPECT in older patients with chronic 
diseases and their medical staff in charge. Intervention 
involves registration with simple comprehensive geriatric 
assessment, establishment of an individualised care plan 
for three chronic diseases (hypertension, diabetes and 
heart failure), medication and rehabilitation management, 
periodic video- conference and in- system assessment after 
intervention period. Primary outcomes are control levels of 
the three chronic diseases, adequacy of drug management 
and overall functional status. Patients will be assessed 
at before and after study period and 3 months after study 
ended. Analysis will be carried out with an intention- to- 
treat principle. In addition to evaluate intervention effects, 
clinical usability and economic evaluation will be assessed.
Ethics and dissemination The study protocol was 
reviewed and approved by the Seoul National University 
Bundang Hospital Institutional Review Board. Study 
findings will be published in peer- reviewed journals.
Trial registration number KCT0004360.
INTRODUCTION
With the rapidly ageing population in Korea, 
the proportion of older adults has doubled in 
just 17 years from 7% (an ageing society) in 
2000 to 14% (an aged society) in 2017 and is 
expected to increase up to 20% (a post- aged 
society) by 2026.1 These elderly individuals 
have higher prevalence of chronic medical 
conditions, along with a higher rate of 
poor self- reported health status, functional 
decline and institutionalisation in long- term 
care hospitals (LTCH) or nursing homes 
(NHs).2 3 Even though most older people 
prefer to reside in their homes with inde-
pendent physical and functional capacity to 
maintain the integrity of their social network 
Strengths and limitations of this study
 ► This is a pioneering study for evaluating the infor-
mation and communication technologies (ICT) based 
healthcare management programme (Health- caRE 
Systems for Patients/Elderly with Coordinated care 
using icT (RESPECT)) tailored for older patients in 
long- term care institutions, with the intention to in-
corporate the investigation of health outcomes using 
a clustered, randomised design.
 ► The study will compare ICT- based multi- component 
management of older patients in long- term care 
hospitals or nursing homes and the usual care 
provided.
 ► Health- RESPECT provides comprehensive geriatric 
assessment, an individualised care plan for hyper-
tension, diabetes and heart failure, information for 
potentially inappropriate medication, a tailored re-
habilitation programme, periodic videoconferencing 
and in- system follow- up assessment.
 ► Health- RESPECT supports medical staff decisions 
by remote consultation of distant professionals, but 
patient participation was limited.
 ► Further research in diverse countries will be nec-
essary because this study will be conducted in only 
one Asian country, and the findings may not be gen-
eralisable to all locales.
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and enjoy a higher quality of life, due to the increase in 
single- person households and women’s participation in 
the labour force, older adults are admitted to long- term 
care institution (LTCH or NH) that provide both medical 
and care support.4 5
Thus, the cost of medical care for older adults is 
expected to increase exponentially, highlighting the 
necessity for alternative, sustainable healthcare systems 
to manage older patients.6 Older patients usually have 
multiple, multidimensional problem lists, and it is diffi-
cult for one expert to decide the optimal care plan. 
However, fragmented medical services in Korea lead to 
challenges in providing integrated medical services to 
older patients with multiple chronic diseases, resulting in 
considerable unmet needs. Digital medicine using infor-
mation and communication technologies (ICT), can be a 
better alternative for institutionalised older patients who 
have difficulty moving or transferring. It can also improve 
control of chronic medical conditions by monitoring or 
quick detection and communication with distant profes-
sionals.7 In older patients with complex multiple disease 
and functional status combinations, the integrated 
services model using ICT, for example, ‘suggestions of 
treatment targets which consider patient’s frailty status’, 
‘providing evaluation tools and automatically suggest 
rehabilitation program based on functional status’ and 
‘selecting inappropriate medicine among automatically 
identified prescribed medicine and recommending the 
appropriate medication according to disease status’ are 
needed.
For effective treatment and management of older 
patients, consultation with distant professionals and 
sharing medical information between acute care hospi-
tals and LTCH or NH, which participate in patient care, 
we developed the Health- RESPECT (caRE Systems for 
Patients/Elderly with Coordinated care using icT), a 
new service model and systems using ICT.8 Through 
qualitative literature review, focus group interviews and 
structured surveys, three chronic diseases (hyperten-
sion, diabetes and heart failure), which are common 
and problematic in LTCH or NH older patients, and 
services that can be provided by using ICT were selected. 
The developed Health- RESPECT includes comprehen-
sive geriatric assessment, management of three chronic 
diseases, individualised rehabilitation, drug manage-
ment and remote video and written consultation 
services.
Therefore, we aimed to examine the effectiveness of 
intervention using Health- RESPECT on the outcomes for 
institutionalised older adults using clustered randomi-
sation design. We hypothesised that intervention group 
would show a significant difference in adequacy of chronic 
disease management, adequacy of drug management and 
assessment of overall functional status compared with 
the control group. Additionally, clinical usability and 
economic evaluation will be assessed.
METHODS AND ANALYSIS
Trial design
The Health- RESPECT study will adopt cluster randomised 
controlled trial (RCT) design with parallel equal arms 
performed in South Korea. The long- term care institu-
tion will be assigned into the cluster by the same category 
(LTCH or NH), and the same number of clusters will be 
allocated to the intervention and control groups through 
randomisation. Thereafter, the patients and medical 
staff recruited from the clusters will be assigned to the 
intervention or control groups. Inclusion of participants 
started on 6 September 2019 with a 3- month intervention 
period and a 3- month follow- up. This study will follow the 
CONsolidation Standards Of Reporting Trials flow chart 
to show the flow of participants through each stage of the 
RCT (figure 1).9
Participants and setting
The study is carried out in 12 long- term care institutions, 
and one additional institution is used as a reserve in case 
some withdraw early from the study. All long- term care 
institutions are administrated under the public health 
insurance or long- term care insurance system in 2019.
There are two groups of study participants. The first 
group includes older patients who (1) are over 65 years 
old, (2) are expected to stay in the facilities for at least 
2 weeks at the point of observation/intervention and 
(3) have at least one or more chronic disease (hyperten-
sion, diabetes, heart failure and so on). Patients who are 
Figure 1 Flow diagram of cluster trial. N, No. of clusters; n, 
No. of elderly patients
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expected to die or be discharged within the 3- month or 
who disagree with study were excluded. The second group 
includes healthcare professionals who (1) are working at 
the participating institutions and (2) have participated 
in the treatment or management of the patients. Study 
participants will provide informed consent to participate 
in the study (online supplemental data). For those partic-
ipants with impaired ability to consent, caregivers can 
act as a proxy to provide agreement to participate in the 
study. Patients may withdraw from the study on request or 
in the case of transfer to a different hospital, discharge or 
death (table 1).
Participants recruitment
Long- term care institutions that are near the study insti-
tute (acute care hospital) and maintain a continuous rela-
tionship for patient transfer and re- transfer were chosen 
as candidates and were recruited through e- mail, phone 
calls and in- person meetings by the research team. Infor-
mation on the research contents and purpose was deliv-
ered to physicians and nursing staff currently working 
in the long- term care institutions. Posters and handouts 
describing the research were also provided to the long- 
term care institutions for the patients. Those medical staff 
and patients were enrolled with written informed consent 
after providing enough information.
Interventions
The interventions are comprised of (1) registration, (2) 
establishment of care plan, (3) management and (4) assess-
ment. Patients were recruited and registered by entering 
basic demographic information in both the interven-
tion and control groups. After Comprehensive Geriatric 
Assessment (CGA), with the established interdisciplinary 
care plan, the Health- RESPECT platform provides an 
individualised management strategy, according to frailty, 
for patients with three chronic diseases (hypertension, 
diabetes and heart failure) to medical staff. Data on 
patients’ vital signs, laboratory findings, diagnosis and 
prescribed medication will be collected from the elec-
tronic medical records (EMRs) of the long- term care insti-
tutions and accumulated in Health- RESPECT. The users 
of Health- RESPECT are medical staffs of LTCH, NHs and 
study institute. Health- RESPECT automatically provides 
recommendations for treatment goals, additional evalua-
tion or tests needed, recommended medications for the 
target diseases (hypertension, diabetes and heart failure) 
based on recent guidelines and potentially inappropriate 
medication (PIM) for older patients. Health- RESPECT 
also includes a function for screening for adverse events 
and generating warning alarms by message or consulta-
tion with the attending physician at the LTCHs, NHs and 
acute care hospitals. Health- RESPECT contains cognitive, 
physical and swallowing rehabilitation services tailored to 
each patient’s level of function, assessed in CGA. Access 
to medical information within Health- RESPECT will be 
granted only to medical staffs. Additionally, tools for 
written consultation or video- conference will be provided 
monthly or as needed. The drug management service 
screens the medications currently being prescribed and 
provides the number and specified drugs corresponding 
to the absolute or potentially inappropriate drug list. After 
the 3- month intervention period, a simple assessment 
of the disease and functional status will be performed 
through Health- RESPECT8 (table 2). If there is a request 
to stop the intervention or observation of the patient or 
family member after recruiting, or even during the study 
period, we drop the participant.
Outcome measures
To collect the outcome indicators, data transmission from 
the EMR of the LTCH or NH to Health- RESPECT occurs 
on average once a month, in both the intervention and 
control group, from the start of the study to 3 months 
after the end of the study. Primary outcomes of this study 
Table 1 Participant inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Patients  ► Over 65 years old.  ► Expect to pass away or discharge within the 3- month 
intervention period.
 ► Expected to have length of stay over 2 weeks at 
point of observation/intervention.
 ► If in coma.
 ► Have at least one or more chronic disease 
(hypertension, diabetes, chronic heart failure and 
so on).
 ► Disagree with the study.
   ► Serious reason that limits the participation and progress 




 ► Works or contracts with a participating 
institution.
 ► If the work is changed during the intervention period 
or the contract is terminated, the work cannot be 
performed.
 ► Participated in the treatment or management of 
the patients.
 ► If the relevant work experience is less than 1 month.
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are adequacy of management for three chronic diseases 
(hypertension, diabetes and heart failure), adequacy of 
drug management and assessment of overall functional 
status. First, to assess disease management status, the 
control rate of the treatment targets for each chronic 
disease (above) will be evaluated. Treatment targets for 
hypertension and diabetes are determined differently 
according to frailty status. The target blood pressure 
for hypertension is 140/90 mm Hg in the robust and 
prefrail groups and 150/90 mm Hg in frail groups. The 
target Hemoglobin A1c (HbA1c) for diabetes is <7.5% 
in robust groups, <8.0% in prefrail groups and <8.5% 
in frail groups, or for random glucose level the target is 
≤190 mg/dL in robust groups, ≤210 mg/dL in prefrail 
groups and ≤230 mg/dL in frail groups. Failure of proper 
heart failure management is defined as an emergency 
room visit or unintended hospitalisation due to acute 
deterioration of heart failure symptoms. Frailty status was 
evaluated with the Korean version of the FRAIL (Fatigue, 
Resistance, Ambulation, Illness, and Loss of weight, 
K- FRAIL) scale. Scores of 3 and more, 1–2 and 0 were 
classified as frail, prefrail and robust, respectively.
Second, to assess the adequacy of drug management 
among older patients with multiple chronic diseases, 
PIMs and number of drugs (polypharmacy) prescribed 
by physicians will be measured. List of PIMs is defined 
by referring to the Beers Criteria and considering the 
medical environment of the long- term care institutions in 
Korea.10 The polypharmacy is defined as the case where 
the patient- specific prescription drug type exceeds the 
standard (eg, 5, 9).11
Third, for the assessment of overall functional status, a 
series of care quality indicators based on functional status 
in the interRAI Long- term Care Facilities (LTCF) Tool 
will be measured and integrated.12 13 The interRAI LTCF 
is a reliable assessment tool for institutionalised people 
with long- term care needs, and it is possible to examine 
the effects of interventions by identifying changes in func-
tional status.12 In this study, a set of functional indicators 
in mental and physical health conditions, and treatment 
domains were measured and computed as a composite 
measure at the individual level in a similar way to the ones 
previously conducted in the Netherlands14 and Korea.15
Secondary outcomes will be measured with the following: 
rehabilitation service management indicators, an indi-
vidual functional measures, quality of life and acute care 
hospital utilisation. Rehabilitation service management 
will be assessed using the Korean Mini- Mental State Exam-
ination for participants’ cognitive function, Functional 
Ambulation Category for evaluation of motor function 
and pneumonia incidence due to swallowing problem. 
Multidimensional functional status will be measured by 
the set of individual measures we used to compute the 
composite functional measure explained above.15 We will 
use the EuroQol- 5 Dimension Korean version, developed 
by the EuroQol, to assess patients’ quality of life.16 Acute 
care hospital utilisation will be measured by the check-
lists of hospitalisations through the emergency room and 
Table 2 Schedule of enrolment, interventions and assessments
Timepoint
Study period
Enrolment (I) Allocation (I) Enrolment (P) Postallocation Close- out
−t2 −t1 0 t1 t2 t3
Enrolment
  Eligibility screen (I) X           
  Informed consent (I) X           
  Allocation (I)   X         
  Eligibility screen (P)     X       
  Informed consent (P)     X       
Interventions
  Health- RESPECT             
Assessments
  (Clinical effectiveness) primary outcomes       Xa Xa   
  (Clinical effectiveness) secondary outcomes       Xb Xb Xb’
  (Clinical usability)         Xc   
  (Economic effect)       Xd Xd’ Xd
I, institutions; P, patients; RESPECT, caRE Systems for Patients/Elderly with Coordinated care using icT; t1, before intervention measurement 
(baseline); t2, after intervention measurement; t3, follow- up measurement (3 months after intervention); Xa, chronic disease management, 
inappropriate medications and overall functional status with a composite indicator; Xb’, acute healthcare utilisations; Xb, functional 
rehabilitation management, functional status with individual indicators, quality of life and acute healthcare utilisations; Xc, patient experiences, 
technology acceptability and healthcare professionals’ experiences; Xd’, cost- effectiveness and willingness to pay; Xd, cost- effectiveness.
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emergency room visits. Even with medical optimisation 
through Health- RESPECT, functional status may change 
slowly over a period longer than 3 months. However, we 
included the functional outcome whether it sharply dete-
riorate during study period because it is important in 
older patients living in long- term care facility.
For clinical usability assessment, a focus group discus-
sion (FGD) and survey will examine the patient and 
healthcare professional experience. An FGD session, held 
separately by each institution, proceeds to the healthcare 
provider with the following semi- structured questions: 
frequency of use, changed work methods, satisfaction 
and usefulness of system components, patient reactions, 
differences from existing systems and changes in the 
method of consultation. Based on the answers to these 
questions, additional questions are presented to identify 
participants’ responses and identify the mechanisms of 
effectiveness and results of the unexpected assistance. 
As in this study, changes due to the introduction of an 
ICT- based system can be expected from the medical 
work perspective as an effect on workflow, general 
merits, communication and information processing 
work. We intend to observe this using Brooke’s System 
Usability Scale (SUS).17 18 SUS consists of 10 simple ques-
tions, and each item is designated from 0 to 100 points 
by converting it to a weight. The higher the score, the 
higher the usability. In addition, the Telehealth Usability 
Questionnaire tool, which measures satisfaction with the 
intervention system, is used to understand the patient’s 
experience as the ultimate beneficiary of this system.19
The economic evaluation will be conducted by cost- 
effectiveness analysis and cost–benefit analysis. For cost 
analysis, medical costs, non- medical costs and programme 
costs will be assessed. Medical cost will be measured by 
the change of healthcare use after the implementation 
of intervention. To analyse the change, the number of 
healthcare use in inpatient setting will be recorded, and 
the average cost of each case will be multiplied to sum 
up the medical cost. Also non- medical cost, such as the 
transfer cost, will be measured by data from the Korea 
Health Panel.20 Cost of programme will be measured by 
a bottom- up approach from the data of the participating 
institutions. The time to conduct the intervention of 
healthcare personnel will be surveyed in medical staff who 
will participate in intervention by asking for the additional 
time used for the intervention. The wage of healthcare 
personnel will be used to value the time of intervention 
conducted. The index of clinical effectiveness will be used 
as the reference in cost- effectiveness analysis. The results 
will be assessed as incremental cost- effectiveness ratio.15 
For the cost–benefit analysis, benefit will be measured by 
willingness to pay. To measure subjective utility of health-
care, willingness to pay will be measured for healthcare 
personnel. Starting bids will be presented as 10 000, 20 
000, 40 000 and 60 000 Korean won. Net benefits will be 
calculated by deducting total cost from the willingness to 
pay values (table 3).
Table 3 Outcome variables




  Chronic disease management Survey (P) and EMR (P) Primary × ×
  Inappropriate medications EMR (P) Primary × ×
  Overall functional status with a composite indicator Assessment using interRAI LTCF (P) Primary × ×
  Functional rehabilitation management Assessment using FAC, MMSE (P) Secondary × ×   
  Functional status with individual indicators Assessment using interRAI LTCF (P) Secondary × ×
  Quality of life Survey using EQ- 5D (P) Secondary × ×
  Acute healthcare utilisation Survey (P) and EMR (P) Secondary × × ×
  Clinical usability
  Patient experience Survey (P) Secondary ×
  Technology acceptability Survey (HCP) Secondary ×
  Healthcare professional experience FGD (HCP) Secondary ×
  Economic effectiveness
  Cost- effectiveness Survey (P) Secondary × × ×
  Willingness to pay Survey (P and HCP) Secondary ×
EMR, electronic medical record; EQ- 5D, EuroQol-5 dimension; FAC, functional ambulation category; FGD, focus group discussion; 
HCP, healthcare professional; LTCF, Long- term Care Facilities; MMSE, mini- mental state examination; P, patient; t1, before intervention 
measurement (baseline); t2, after intervention measurement; t3, follow- up measurement (3 months after intervention).
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Data collection and management
Research nurses (assessors) who are registered in the 
study will conduct all data collection according to the 
standard guidelines. Research nurses will be trained 
through an 8- hour educational programme that consists 
of an overview of the study, measurement tools and prac-
tice sessions with scenarios prior to data collection and 
review for errors. Additional training and practice will 
be provided if needed. All patients in the intervention 
and control groups will be asked to complete an assessor- 
administered survey before (T1) and after completion of 
intervention or observation (T2, follow- up). Qualitative 
(FGD) and quantitative (usability survey and willingness- 
to- pay survey) data for medical staff will be collected after 
completion of the intervention (T2).
To improve the reliability of data quality, some cases will 
be evaluated by two independent assessors. Throughout the 
whole data collection period, real- time support using instant 
message or phone call for assessors will be provided. Asses-
sors will enter the data collected during the survey period 
in a web- based data collection programme and Microsoft 
Excel, and research team members will review according to 
defined monitoring strategies and double- check for missing 
data and unusual responses. If any errors are found in the 
data, the data managers will ask the assessors for correction 
or clarification, and all the corrections will be made after 
the Data Monitoring Committee’s (DMC) confirmation. 
Furthermore, to promote follow- up and retention, assessors 
will report any issues with the patients. If any discontinu-
ation of research participation occurs, a brief short form 
report will be generated and reported immediately. All of 
the completed survey data will be checked and collected 
by research team members. All patients will be assigned a 
unique research ID, and the research team will train the 
assessors to secure the research data to maintain its safety. 
The data collection forms will not contain any identifiable 
personal information. An electronic password- protected 
file will be saved in a password- protected computer. DMC 
consists of the investigators of the evaluation team as well as 
data managers and a statistician who manage data quality in 
the data collection, analysis, auditing and reporting inter-
vention process. DMC is held regularly once a month and is 
independent from the sponsor and has no competing inter-
ests. The interventions which will be provided in this study 
is unlikely affect the safety of participants because the inter-
ventions are mainly non- invasive ICT- based professional 
collaboration. However, if any problem is reported during 
the monitoring process, it will be immediately reviewed 
by the DMC and reported to the Seoul National Univer-
sity Hospital (SNUBH) Institutional Review Board (IRB). 
The datasets generated and/or analysed during the current 
study do not allow opening or sharing with any third party 
due to the policy of the SNBH IRB but are available from 
the corresponding author on reasonable request.
Sample size
The sample size calculation was performed based on 
the primary clinical outcome of adequacy of drug 
management, defined as reduction of prescription of 
PIM. According to a literature review and a previous 
study conducted by the research team, we expect that the 
intervention will reduce PIM by a further 20% compared 
with the control group.21 Assuming a 5% significance, 
80% power and an intracluster correlation coefficient of 
0.01,14 15 we calculated that we needed 480 participants—
for RCT with two different arms. Allowing for an attrition 
rate of 25%, a total of 640 participants (320 participants 
per group) will be recruited. Additionally, we will recruit 
all healthcare professionals (5–15 medical doctors and 
nurses per institution for a maximum of 100) who will 
participate in the study.
Randomisation
This study employs a stratified cluster randomised 
design. The unit of randomisation is the institution, as 
we randomised each institution and all of its participating 
patients into the intervention and control group. Since 
Health- RESPECT was developed for this study and applied 
for the first time, medical staff and patients who participate 
in this study have never been exposed to Health- RESPECT. 
We conducted systematic random sampling by listing the 
institutions in order of largest proportion of older adults 
aged over 75 in LTCH and NH, respectively. Patients were 
allocated into the intervention and control group with 
1:1 ratio, and we checked that imbalance rate between 
the groups did not exceed 20%. The final data set is blind 
coded for randomisation. To maintain blindness during the 
assessment and analysis process, assessors and a statistician, 
who are separate external personnel managed by the DMC, 
are not disclosed to whether they are subject to the inter-
vention arm by randomisation. External assessors and the 
statistician remain blind until their role is complete.
Statistical analysis
The main analysis will be conducted based on intention- 
to- treat principle. As a preliminary analysis, we will detect 
any significant difference in basic characteristics between 
clusters during the baseline period via χ2 test and analysis of 
variance. To account for the clustered data structure, we will 
apply a multilevel regression analysis and use a generalised 
linear mixed effects model, including both fixed factors 
(time and intervention) and random factors. Two random 
effects will be introduced, one at the institution (cluster) 
level and the other at the patient (individual) level. To 
evaluate any significant benefit of the intervention, we will 
present the test statistics. We will use two- sided p values with 
α=0.05 for level of significance. As a secondary analysis, we 
will include the potential confounding prerandomisation 
variables as additional fixed effects in the regression model 
to derive the confounder- adjusted intervention effect. Also, 
we will explore the duration effect of the intervention by 
comparing the intervention period and follow- up period 
by appending an interaction term between time and inter-
vention in the regression model. For each of the aforemen-
tioned analyses, we will implement imputation or inverse 
probability weighting methods to adjust for any kind 
of missing data. Sensitivity analyses to assess the effect of 
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attrition and inclusion of patients and subgroup analyses to 
examine the difference in LTCH and NH settings will also 
be conducted.
Patients and public involvement
When developing the Health- RESPECT, patients were 
participated with focus group interviews (one patient 
and two family member, one caregiver) and structured 
survey (3 patients, 38 family members or 9 caregivers) to 
identify patients’ priorities, experience and preference. 
During the study, patients were assessed before and after 
3 months of study period. Although patients in the inter-
vention group will not be able to access medical recom-
mendation provided through Health- RESPECT, but will 
be able to watch videos of physical or cognitive rehabili-
tation tailored to each individual. There are no plans to 
disseminate the results to study participants.
ETHICS AND DISSEMINATION
This study is sponsored by the Ministry of Health & 
Welfare, Republic of Korea, and centrally managed by 
staff at Seoul National University Bundang Hospital and 
registered with the Clinical Research Information Service 
Registry. The trial sponsor has no role in the design or 
conduct of the trial. The protocol was first reviewed by 
the SNUBH IRB on 19 July 2019 and lastly revised on 19 
May 2020 for clarification of specific number of study 
participant group (patients and medical staff), detailed 
cluster randomisation process, method for data transfer 
and non- face- to- face evaluation as an alternative method 
when face- to- face evaluation is not possible due to 
pandemic of COVID-19 (IRB No. B-1904/534–304). The 
current protocol version is version 1.3, and there is no 
plan to change the current protocol.
The risk of negative effects on patient outcomes is thus 
minimal. The potential of not having a positive effect 
from the intervention on Health- RESPECT competence 
is present in control group. Health- RESPECT provides 
recommendations based on published clinical guidelines 
for hypertension, diabetes and heart failure or PIM for 
older patients. Despite the potential risk which might 
caused by Health- RESPECT is very low, additional consul-
tation between medical staff in long- term care facilities 
and regional acute care hospital (study institute) will 
be provided if the patient's problem list is not resolved 
with the information provided by Health- RESPECT, or at 
whenever health- care professional wants. All of the partic-
ipants will signed informed consent and will be recruited 
on a voluntary basis. If the patient lose their ability to 
make decisions, the information for this study will be 
provided their guardians and the guardians will signed 
informed consen. At the completion of the trial, the data 
will be analysed, and the study findings will be published 
in major peer- reviewed journals.
DISCUSSION
A cluster randomised controlled trial will be conducted 
to examine the feasibility, effectiveness and safety of the 
Health- RESPECT in older patients with chronic diseases 
and their medical staff in charge. Intervention involves 
registration with simple comprehensive geriatric assess-
ment, establishment of a personalised treatment strate-
gies for three chronic diseases (hypertension, diabetes 
and heart failure), medication and rehabilitation 
management, periodic video- conference and in- system 
assessment after intervention period. Although the 
Health- RESPECT platform has not been commercialised, 
we think an ICT service that provides medical informa-
tion about specific diseases or medications and a consul-
tation function to distant professionals, for older patients 
in long- term care facilities, will become more useful for 
management without contact in the pandemic infectious 
disease period.
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